SHTDY (Sinopharm Group Co) GF Value Rank: 8 (As of Jul. 11, 2026) — 14% Above Median


SHTDY Sinopharm Group Co Ltd SHTDY
73 GF Score
Price $10.65
GF Value $13.29
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Sinopharm Group Co GF Value Rank?

Sinopharm Group Co SHTDY -0.28% 73 GF Value Rank is 8 as of Jul. 11, 2026, which is 14% above its 10-year median of 7.00. GuruFocus rates SHTDY with a GF Score™ of 73/100 and a GF Value™ of $13.29 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Sinopharm Group Co has the GF Value Rank of 8.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


Sinopharm Group Co GF Value Rank Related Terms


SHTDY vs MCK, CAH, COR: GF Value Rank Comparison

For the Medical Distribution subindustry, Sinopharm Group Co's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinopharm Group Co GF Value Rank vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sinopharm Group Co's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Sinopharm Group Co's GF Value Rank falls into.


SHTDY
73GF Score
Sinopharm Group Co Ltd SHTDY
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Value Rank →
What does a GF Value Rank of 8 mean?
Sinopharm Group Co (SHTDY) has a GF Value Rank of 8 as of Jul. 11, 2026. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Sinopharm Group Co and its competitors. This is 14% above median its historical median of 7.00. Over the past decade, Sinopharm Group Co's GF Value Rank has ranged from 1.00 to 10.00.
Is Sinopharm Group Co's GF Value Rank too high?
Sinopharm Group Co's current GF Value Rank of 8 is 14% above median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, Sinopharm Group Co has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sinopharm Group Co's GF Value Rank compare to MCK and CAH?
Sinopharm Group Co's GF Value Rank of 8 can be compared against companies in the Medical Distribution industry. Historically, Sinopharm Group Co's own GF Value Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value Rank for a Medical Distribution company?
A good GF Value Rank depends on the Medical Distribution industry context. However, GF Value Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value Rank mean?
A high GF Value Rank can signal that a stock is expensive relative to its fundamentals. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Sinopharm Group Co and its competitors. Sinopharm Group Co's current GF Value Rank is 8, which is 14% above median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinopharm Group Co stock overvalued right now?
Based on GuruFocus' analysis, Sinopharm Group Co (SHTDY) is currently considered Modestly Undervalued. The stock's GF Value™ is $13.29, compared to a current price of $10.65 — trading 19.9% below its estimated fair value. The current GF Value Rank is 8, which is 14% above median its 10-year median of 7.00. Sinopharm Group Co's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value Rank calculated?
GF Value Rank is calculated from a company's financial statements. For Sinopharm Group Co (SHTDY), the current GF Value Rank is 8 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sinopharm Group Co (SHTDY) Overvalued in 2026?

Based on GuruFocus' analysis, Sinopharm Group Co stock appears to be undervalued. The current stock price of $10.65 is trading 19.9% below its estimated GF Value™ of $13.29. GuruFocus considers Sinopharm Group Co to be Modestly Undervalued.

Key valuation signals for SHTDY:

  • GF Value Rank: 8 (14% above median its 10-year median of 7.00)
  • GF Value™: $13.29 vs. price of $10.65 (19.9% below fair value)
  • GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the SHTDY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sinopharm Group Co Business Description

Address No. 385, East Longhua Road, Sinopharm Group Building, Huangpu District, Shanghai, CHN, 200023
Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2024. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.
73GF Score

Get the complete analysis for SHTDY

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.65
Price
$13.29
GF Value